Comparing PET/CT and MRI scans in stomach cancer
Part of Cancer, Digestive system clinical trials.
This study looks at images from two types of scans (a PET/CT and an MRI) taken of people with stomach cancer. It aims to see how well these scans work together to show the cancer, which could guide better treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or are suspected to have stomach cancer.
- You've already had a special PET/CT scan (18F-FAPI) for your stomach.
- You've also had a stomach MRI with and without contrast dye.
- You don't have any other active cancer, or a past cancer within the last 5 years.
- You are free of severe health problems or active infections, and can agree to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses two types of PET/CT scans (FDG and FAPI) to see how well chemotherapy or other treatments work before surgery for stomach cancer that has spread to the lining of the abdomen. The goal is to find the best way to measure treatment response and help guide your care.
This study compares two types of PET scans (FAPI and FDG) to see which one works better for diagnosing stomach cancer. You would receive both scans within a week, and your doctor would also check your blood for tumor markers.
This trial tests whether a special PET/CT scan (using a drug called [18F]F-FAPI) and a laparoscopy (a small camera through the belly) can better show the spread of advanced stomach or esophagus cancer before surgery. The goal is to help doctors decide the best treatment plan.
This trial uses three different MRI scanning sequences to see which best helps stage (determine the spread of) stomach cancer. The goal is to improve how doctors plan treatment for gastric cancer.
This trial studies how two types of scans—multi-parameter MRI and special CT (dual-energy CT)—look in people with confirmed stomach cancer before surgery. It may help doctors better understand the cancer and improve planning based on scan features.
This trial compares two imaging techniques, a new type of PET/MRI with a special tracer called FAPI versus a standard tracer called FDG, to see which is better at detecting spread of rectal cancer to nearby lymph nodes. The results may help doctors choose the best scan for planning your surgery.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.